Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
27,773 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
When headlines shout about a stalled housing bill, borrowers can feel exposed. This article breaks down what the stal...
Meme coins grab headlines and wallets alike. This guide dives into Dogecoin and Pepe, breaking down what makes each t...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
A big trade in a technology-focused ETF last quarter offers more than a headline. This article digs into what investo...
A recent price retreat for AMD has more to do with market nerves than a broken thesis. This article lays out why inve...
A mid-sized fund wrapped up a $9 million exit from a major pawn shop operator after a rally of about 150% over the ye...
If you’re considering Walmart stock, you should understand three core ideas that drive the business and the stock's p...
Social Security remains a cornerstone of retirement income, but 2026 brings changes that could affect when and how yo...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Lantheus is steering a strategic shift toward PET radiodiagnostics, aiming to unlock new growth. This article breaks ...
This guide dives into Arbe's Q2 2025 earnings, decoding revenue growth, margins, and guidance. Learn actionable ways ...